Normocytic Anemia | Clinical Medicine

Main ideas / lessons in the video

1) Scope: what “normocytic anemia” is (context for an anemia series)

The speaker places this topic within a broader anemia framework:

• Microcytic anemia → another video
• Normocytic anemia → this video
• Macrocytic anemia → another video

2) Core definitions used throughout

Anemia by hemoglobin

• Male: Hb < 13 g/dL
• Female: Hb < 12 g/dL

Normocytic classification by MCV

• MCV 80–100 fL → normocytic
• (MCV < 80 fL would be microcytic; > 100 fL macrocytic)

3) Pathophysiology framework for normocytic anemia

The speaker emphasizes that normocytic anemia is driven by causes different from the “heme synthesis problem” pattern seen in microcytic anemia. Key mechanisms include:

• Underproduction of red blood cells (bone marrow not producing enough)
• Loss of red blood cells from circulation (e.g., acute blood loss)
• Hemolysis (RBCs destroyed), subdivided into:
  • Intrinsic hemolysis (problem within RBC)
  • Extrinsic hemolysis (problem outside RBC)

---

Diagnostic methodology (algorithm-like guidance, stepwise)

A) Use reticulocyte index to decide underproduction vs compensation

1. Start with normocytic anemia (MCV 80–100)
2. Check reticulocyte index:
   • Low reticulocyte index (< 2%) → underproduction
     • Bone marrow is failing or not receiving/processing signals to make RBCs.
   • High reticulocyte index (> 2%) → loss and/or hemolysis
     • Bone marrow is compensating.

B) If underproduction (low retic index): main causes

1. Aplastic anemia

• Intrinsic bone marrow failure (stem cell proliferation/differentiation fails).
• Mentioned causes:
  • Chemo/radiation/drugs
  • Autoimmune stem-cell attack
  • Idiopathic
  • Later noted: infections (e.g., parvovirus B19)

2. Anemia of chronic disease (anemia of inflammation)

Mechanisms described:

• ↓ EPO signaling
• ↓ iron availability via hepcidin-mediated iron sequestration
  • Iron trapped in macrophages
  • Reduced gut absorption / reduced iron delivery to marrow

Additional notes:

• Early may remain normal MCV, later can become microcytic
• Clues emphasized:
  • Often normal or low serum iron with high ferritin
  • Iron studies guide diagnosis

C) If high retic index: loss vs hemolysis distinction

Hemolysis-focused labs

• LDH (often elevated)
• Haptoglobin (often low)
• Indirect bilirubin (often elevated)
• Urine tests:
  • Hemoglobinuria
  • Hemosiderinuria (and dark urine clues)
• Supporting signs:
  • Splenomegaly
  • Jaundice

Decision logic

• Hemolysis labs negative + evidence of bleeding → acute blood loss anemia
• Hemolysis labs positive → hemolytic anemia pathway

D) If hemolytic anemia suspected: intrinsic vs extrinsic categorization

Intrinsic hemolysis (problem in RBC)

• Membrane defects
  • Hereditary spherocytosis
  • PNH (paroxysmal nocturnal hemoglobinuria) described as a membrane protein anchor defect
• Hemoglobinopathies
  • Sickle cell anemia (HbS) described in detail
• Enzyme deficiencies
  • G6PD deficiency

Extrinsic hemolysis (problem outside RBC)

• Autoimmune hemolytic anemia
  • Warm (IgG-mediated)
  • Cold (IgM + complement-mediated)
• MAHA (microangiopathic hemolytic anemia)
  • RBCs sheared by microthrombi

---

Detailed concepts: hemolysis patterns (intravascular vs extravascular)

A) Intravascular hemolysis (RBC destroyed in bloodstream)

Lab constellation emphasized:

• ↑ LDH
• ↓ haptoglobin
• Hemoglobin in urine (hemoglobinuria) → dark urine; possible false-positive dipstick
• Hemosiderinuria also described

Key concept:

• Free hemoglobin is harmful (including renal injury risk and nitric oxide scavenging).

The speaker states two hemolytic causes primarily showing intravascular hemolysis:

• PNH
• MAHA (microangiopathic hemolytic anemia)

B) Extravascular hemolysis (RBC destroyed in spleen by macrophages)

Lab/clinical emphasis:

• ↑ indirect (unconjugated) bilirubin
• Splenomegaly
• Jaundice (from unconjugated bilirubin)

Special note:

• Indirect/unconjugated bilirubin is the highlighted bilirubin pattern here.

Causes primarily extravascular (as stated by speaker):

• Hereditary spherocytosis
• Autoimmune hemolytic anemia

---

Cause review (high-yield lists)

1) Underproduction: aplastic anemia vs anemia of chronic disease

Aplastic anemia

• Bone marrow failure → pancytopenia emphasized:
  • ↓ WBCs (leukopenia)
  • ↓ RBCs (anemia)
  • ↓ platelets (thrombocytopenia)
• Clinical complications: infections, bleeding, fatigue
• Confirmatory concept: bone marrow biopsy shows hypocellular marrow

Anemia of chronic disease

• Inflammation → hepcidin → iron sequestration
• Inflammation → lower EPO signaling
• Diagnostic approach emphasized: iron studies
  • ↑ ferritin, ↓ iron, and lower TIBC/transfer studies described

2) Loss: acute blood loss anemia

• Retic index concept:
  • Bone marrow intact → reticulocytes rise
• Causes mentioned / red flags:
  • AAA rupture
    • pulsatile abdominal mass, flank/abdominal pain, hypotension
  • Trauma / iatrogenic bleeding
  • GI bleeding:
    • hematemesis (upper GI)
    • melena
    • bright red blood per rectum (lower GI)
  • Heavy obstetric bleeding:
    • postpartum hemorrhage
    • ruptured ectopic pregnancy

3) Hemolytic anemia: intrinsic/extrinsic subtypes

Intrinsic hemolysis

Hereditary spherocytosis (membrane defect)

• RBC become spherical → spherocytes
• Primary destruction in the spleen → extravascular hemolysis
• Complications:
  • Splenomegaly
  • Jaundice (↑ unconjugated bilirubin)
  • Black pigment gallstones risk

PNH (paroxysmal nocturnal hemoglobinuria) (membrane anchor defect)

• Mutation in PIGA gene → deficient GPI anchor
• Loss of complement regulators CD55/CD59
• Complement-mediated RBC destruction → intravascular hemolysis
• Key clinical clue: dark urine in early morning
• Major complication emphasized: thrombosis (hypercoagulable state)
  • Clots in unusual locations noted:
    • hepatic/portal/cerebral veins
    • Budd–Chiari and CVST examples

G6PD deficiency (enzyme deficiency)

• Defective NADPH generation → reduced glutathione → oxidative stress during triggers
• Oxidation-denatured hemoglobin forms:
  • Heinz bodies
  • Spleen produces bite cells
• Can cause both intra- and extravascular hemolysis depending on extent
• Triggers emphasized:
  • Infections (e.g., pneumonia)
  • Drugs:
    • antimalarials
    • sulfonamides (e.g., “Bactrim” style)
    • nitrofurantoin
  • Dietary: fava beans
• Typical smear concept: Heinz bodies / bite cells

Sickle cell anemia (HbS hemoglobinopathy)

• Point mutation → abnormal beta globin → HbS
• Polymerization triggers:
  • acidosis
  • hypoxia
  • dehydration
  • extreme temperatures
• Causes:
  • sickling → intravascular and extravascular hemolysis
  • vaso-occlusive events
• Major complications listed:
  • Splenic infarction → functional asplenia → infection risk (encapsulated organisms)
  • Splenic sequestration crisis (rapid Hb drop, hypotension)
  • Stroke risk; Moya Moya from collateral formation
  • Dactylitis (hands/feet swelling)
  • Avascular necrosis (femoral head/ humeral head)
  • Osteomyelitis risk (examples: Salmonella, Staph aureus)
  • Priapism
  • Renal papillary necrosis (hematuria, flank pain; imaging sign mentioned)
  • Acute chest syndrome (hypoxia, increased work of breathing, chest pain, infiltrate)
  • Aplastic crisis (parvo B19; pancytopenia + rapid Hb drop + low retics)

Extrinsic hemolysis

Autoimmune hemolytic anemia (AIHA)

• Antibody-mediated

Cold AIHA

• IgM-mediated → complement activation (C3)
• Extravascular hemolysis emphasized in spleen
• Complication: acrocyanosis (bluish hands/feet discoloration)
• Secondary triggers mentioned: mycoplasma pneumonia, EBV; often idiopathic

Warm AIHA

• IgG-mediated
• Often idiopathic; if not, consider malignancy (e.g., CLL) or autoimmune disease (e.g., SLE)

Shared features:

• spherocytes
• splenomegaly and jaundice

MAHA (microangiopathic hemolytic anemia)

• Mechanism: RBC shearing by microthrombi → schistocytes
• Platelet consumption → thrombocytopenia
• Subtypes with distinguishing patterns:
  • DIC
    • abnormal coagulation parameters (↑ PT/aPTT/INR-like, ↑ D-dimer; ↓ fibrinogen)
    • often triggered by sepsis/obstetric issues
  • TTP
    • clinical mnemonic (“FAT RN” listed)
    • reduced/low ADAMTS13 mentioned
  • HUS
    • follows diarrheal illness
    • hemolysis + thrombocytopenia + acute kidney injury
    • no neuro symptoms noted as typical here
  • HELLP
    • pregnancy-related
    • hemolysis + elevated LFTs + low platelets
    • sometimes proteinuria mentioned in context of preeclampsia

---

Treatment guidance (by anemia category; includes key thresholds)

1) Blood transfusion general principles

Hemoglobin response rule

• 1 unit packed RBC → raises Hb by ~1 g/dL

Transfusion thresholds stated

• Hb < 7 g/dL if stable and asymptomatic → transfuse to ~7
• Hb < 8 g/dL with CAD/heart failure/pre-surgery → aim above ~8
• Acute coronary syndrome:
  • may target >10 (noted as controversial)
• Hemodynamically unstable / hemorrhagic shock:
  • no strict Hb threshold; transfuse to achieve stability

2) Etiology-specific treatments

Aplastic anemia

• Remove offending cause if possible (stop suspected drugs, avoid exposures)
• Immunosuppression when transplant not feasible:
  • cyclosporin
  • anti-thymocyte globulin
• Bone marrow/stem cell transplant:
  • rough selection noted: <50 with suitable donor → transplant
  • otherwise immunosuppression

Anemia of chronic disease

• Treat underlying inflammatory condition (RA/SLE/malignancy → immunosuppression; inflammation control)
• CKD-related anemia addressed separately:
  • if Hb < 10 → use EPO/ESA to reduce transfusion needs

Acute blood loss

• Transfuse + stop the bleeding source:
  • GI bleed procedures (endoscopy/colonoscopy)
  • surgical/angiographic control for internal bleeding
  • obstetric interventions for postpartum hemorrhage/ectopic rupture

Hemolytic anemia

Hereditary spherocytosis

• Give folate
• Ensure vaccinations prior to splenectomy
• Consider splenectomy for recurrent/severe hemolysis

PNH

• Complement inhibition with eculizumab
• Stem cell transplant mentioned if bone marrow involvement/pancytopenia

G6PD deficiency

• Stop trigger (e.g., offending drugs)
• Avoid fava beans
• Treat infections; episodes improve with removal of oxidative stressors

Sickle cell anemia

• Chronic:
  • folate
  • vaccinations
  • hydroxyurea for frequent vaso-occlusive crises (increase HbF, reduce sickling)
  • stem cell transplant considered as definitive but conditional
• Acute vaso-occlusive crisis:
  • pain control
  • IV fluids
  • oxygen
  • address triggers (avoid hypoxia/acidosis/dehydration)
  • if persistent/severe: transfusion (simple or exchange depending on scenario)
• Transfusion scenarios noted:
  • Simple transfusion for severe symptomatic anemia, aplastic crisis, splenic sequestration crisis, etc.
  • Exchange transfusion preferred for:
    • acute chest syndrome
    • stroke
    • refractory priapism

Autoimmune hemolytic anemia

• Warm AIHA:
  • immunosuppression; corticosteroids emphasized
  • refractory: rituximab
  • final refractory step: splenectomy
• Cold AIHA:
  • avoid cold; supportive and immunologic management implied (rare; “avoid cold” first-line)

MAHA

• DIC: supportive care + component transfusions guided by labs
  • platelets, FFP for INR
  • cryoprecipitate for low fibrinogen
• HUS: “dialysis/support” implied when severe renal failure; pregnancy-related variants mentioned separately
• HELLP: delivery emphasized in pregnancy context
• TTP: plasma exchange emphasized (remove pathogenic components/antibodies and replace plasma; ADAMTS13-related concept)

---

Speakers / sources featured (end list)

• Primary speaker: “Zach” (referred to in subtitles as “Zach”; exact host identity otherwise not provided)
• Sources/citations: None explicitly named (educational/clinical content; no external organizations or papers directly cited)